Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. HRTS: which is better?

Bottom line

PRHSX vs HRTS: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 54% by weight.

But PRHSX is far broader, holding 279 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.

HRTS is cheaper at 0.75% vs 0.83% — a difference of $8.00 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +17.7% for PRHSX.

Updated Nov 19, 2026

PRHSX vs HRTS side by side

PRHSXHRTS
TypeMutual fundETF
Fund familyT. Rowe PriceInnovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.75%
Annual cost per $10k$83$75
10-yr cost on $10k (prospectus)$1,025$1,168
Max front load—None
12b-1 fee—0%
1-yr return+17.7%+23.6%
5-yr return (annualized)+4.2%—
10-yr return (annualized)+9.1%—
Best quarter+23.5%+15.8%
Worst quarter−15.8%−12.4%
Net assets (fund)$11.9B$51.9M
Number of holdings27945
Portfolio turnover62%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXHRTSDifference
2025+17.7%+23.6%−5.9%
2024+1.8%+3.6%−1.8%

Source: Fund prospectus bar charts

Holdings overlap

12 of PRHSX's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingPRHSXHRTS
Eli Lilly & Co14.28%11.52%
Johnson & Johnson6.63%3.59%
Unitedhealth Group Inc5.99%5.24%
Abbvie Inc5.10%2.40%
Merck & Co. Inc.4.01%4.27%
Gilead Sciences Inc2.82%3.43%
Thermo Fisher Scientific Inc2.52%3.97%
Vertex Pharmaceuticals Inc2.28%2.93%
Bristol-myers Squibb Co2.11%2.09%
Abbott Laboratories1.89%2.61%
Amgen Inc1.82%1.91%
Danaher Corp1.43%2.66%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between PRHSX and HRTS?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 54% by weight. But PRHSX is far broader, holding 279 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
Which is cheaper, PRHSX or HRTS?
HRTS has the lower expense ratio (0.75%).
Should I own both PRHSX and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.